Loading
Everything in development, the open problems and what is being done about them, the roadmaps, and what changed on this record.
What is in development for Hypopharyngeal cancer, drawn from the whole corpus: 5 items. Drugs are grouped by the most advanced trial phase they have reached anywhere; approved treatments sit under standard of care. Technologies are the methods being tested for this cancer, trials are the studies recorded here, and ideas are proposals not yet in a trial.
Survival has barely improved in thirty years.
Choosing between preservation and laryngopharyngectomy in the most extensive tumours.
Swallowing, stricture and aspiration after chemoradiation.
Late presentation in the heavy smokers and drinkers who get the disease.
Dated changes read from the records linked to this cancer: approvals, regulatory steps, reported trials, guideline versions and milestones. Newest first; no date is inferred.
On EdgeAll 11 changes by month →When this page itself was last checked or edited.
Median EFS 59.
Three-year disease-free survival 63.
A milestone in how this cancer is treated.
OS 14.
A milestone in how this cancer is treated.